What Does the Election Mean for the Fight to End Prostate Cancer?

This year’s election has been unconventional, even unprecedented. While any new administration brings change and uncertainty, many in the health policy community believe this administration will bring a flurry of activity not seen since the crafting of the Affordable Care Act. In such times, patient advocacy groups like ZERO play a critical role in protecting patient rights, access to care, and cancer research funding. ZERO also will look for opportunities within the changing landscape to improve patient outcomes, like reformation of the role of U.S. Preventive Services Task Force as it relates to PSA screening for prostate cancer. 

ZERO’s vigilance, engagement, and commitment to patients is heightened in this time of uncertainty around what opportunities and threats exist in the new administration’s health care agenda.

One thing we are certain of is that we need your voice. To find stay abreast of how the new administration will impact the fight against prostate cancer, sign up for our advocacy updates to receive ongoing updates on news and opportunities for engagement.

The Cubs Win the World Series and ZERO Visits Chicago for LUGPA

ZERO was there to see the Cubs win the World Series and attend the Large Urology Group Practice Association’s (LUGPA) Annual Meeting in Chicago last week, where we discussed important issues in the prostate cancer community.

It was great to see our Premier Run/Walk Sponsor, AbbVie, as well as the many urology practices, sponsors, and partners who have joined us on our journey to end prostate cancer. Each year we partner with more than 40 urology practices around the country to bring vital prostate cancer awareness to local communities. Thanks to the generous support of these practices, we are able to reach communities with the lifesaving message of early detection, as well as vital fundraising for education, awareness, and research.